Japan sets 50 pct price cut for Opdivo cancer drug: Ono Pharma

Nov 16 (Reuters) - A Japanese health ministry council has

approved a 50 percent cut in the price of Opdivo, a costly

immune system-boosting cancer drug produced by Bristol Myers

Squibb Co and marketed in the country by Ono

Pharmaceutical Co Ltd.

Read more